ArticleNeurotoxicology2025
PCB 37 (3,4, 4'-trichlorobiphenyl) increased apoptosis and modulated neuronal morphogenesis in primary rat cortical neuron-glia cocultures in a concentration-, sex-, age-, and CREB-dependent manner.
Article in Neurotoxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Pollutants regulate changes in pathological markers of neurodegenerative diseases: a new perspective in environmental toxicology.Frontiers in toxicology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Higher-chlorinated (HC) polychlorinated biphenyls (PCBs) are known developmental neurotoxicants. In contrast, there are limited data regarding the developmental neurotoxicity of lower-chlorinated (LC) PCBs despite the increasing environmental prevalence and detection of LC-PCBs in contemporary human tissues, including the perinatal brain. This study characterized the neurotoxic effects of the LC-PCB congener PCB 37 in primary male and female rat cortical neuron-glia co-cultures. Cultures were exposed to varying concentrations of PCB 37 for 48 h beginning on day in vitro 0 or 7. Cell viability was assessed by measuring lactate dehydrogenase release into the culture medium and the percentage of live cells identified using Calcein-AM and Hoechst staining. Apoptosis was measured using fluorometric assays of caspase 3/7 activity and Annexin V binding. Axonal and dendritic growth were quantified in neurons immunostained for Tau-1 or transfected with MAP2B-red fluorescent protein, respectively, using automated image analysis protocols. At environmentally relevant concentrations (0.0001, 0.1, and 100 nM) that did not affect cell viability, PCB 37 caused sex-, age-, and concentration-dependent increases in apoptosis, axonal, and dendritic growth. Pretreatment with the CREB inhibitor 666-15 (500 nM) blocked the effects of PCB 37 on apoptosis and dendritic morphology but not axonal growth. These findings suggest that the pro-apoptotic and dendrite-promoting effects of PCB 37 are mediated by CREB signaling, but that CREB-independent mechanisms underlie PCB 37 effects on axonal growth. Overall, these findings identify PCB 37 as a potential developmental neurotoxicant and further support increasing evidence identifying CREB as a convergent mechanism of developmental neurotoxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.